News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
David Foureau: My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program
Photo taken from: David Foureau/LinkedIn
Feb 17, 2024, 19:52

David Foureau: My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program

David Foureau, Associate Professor, Research Group Director at Levine Cancer Institute Atrium Health, posted the following on LinkedIn:

“My deepest gratitude to the Purple Promise Foundation for their continued support of our melanoma immunotherapy research program. This $100,000 grant will be used to study strategies to redirect immunotherapy for recurring melanoma patients.”

Source: David Foureau/LinkedIn

cancer David Foureau OncoDaily Oncology Purple Promise Foundation
Special Coverage
Blog
Jan 31, 2025, 22:43
Yakup Ergün: External-beam radiation versus TACE for HCC
Blog
Jan 31, 2025, 22:43
Mark Lewis: Running, walking, and crawling are all moving forward, just at different speeds
Insight
Jan 31, 2025, 22:43
Issa Mohamad: Survey of Current Practices for Early-Stage Glottic Squamous Cell Carcinoma
Blog
Jan 31, 2025, 22:43
Monika Pansari: Early detection saves lives
Blog
Jan 31, 2025, 22:43
Bhavin Vadodariya: Team work in cancer surgery
Blog
Jan 31, 2025, 22:43
Europe, the time is now: Liver health can’t wait - ELPA
Blog
Jan 31, 2025, 22:43
Wafaa Rashed: Honored to feature Catherine Metayer in this episode of the PAPERI Bright Minds Series
Blog
Jan 31, 2025, 22:43
The first outreach of the year took us to Stem Child Care Academy - Medicaid Cancer Foundation
Blog
Jan 31, 2025, 22:43
Olubukola Ayodele: Thankful to participate in the Cancer Symposium at the University of Leicester
Blog
Jan 31, 2025, 22:42
Transcriptional States and Dynamics of Circulating Tumor-Infiltrating Lymphocytes during Immunotherapy
Insight
Jan 31, 2025, 19:25
Tanja Obradovic: New Phase III trial with an innovative MOA may soon change the standard of care for second-line MSS CRC
Blog
Jan 31, 2025, 18:05
Shining a light on the EU-funded projects - Association of European Cancer Leagues